Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value

The 150-year-old drugmaker is the first company in health care to hit the milestone.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Corporations, Dave Ricks, Diabetes, Drugs (Pharmaceuticals), Eli Lilly and Company, GLP-1 RAs (Drug), Insulin, Lilly Endowment, Prices (Fares, Fees and Rates), Stocks and Bonds, Trump, Donald J
←9 Books That Showcase The Legacy Of Hip Hop
Inside Mai Pham’s Re-Created Childhood Bedroom: From YouTube Dreams To Family Healing→

More posts

  • CJ ENM Hong Kong Sells Package Of Thai Dramas To Amazon MX Player In India 

  • How Grindr’s C.E.O. Adopted A.I.: ‘I Just Imposed It’

  • Colin Farrell, Steve Coogan, Charlie Heaton, Domhnall Gleeson, Himesh Patel, Niamh Algar & Simone Kirby Join Rich Peppiatt’s Netflix-Backed ‘Bad Bridgets’

  • AIPAC-linked money floods a Denver primary as DeGette fights for survival

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube